Colgate-Palmolive (India) Ltd (COLPAL) Q2 FY27 Results Analysis: Sales Jump 12.2%, EBITDA Margin Compresses 282 bps
Colgate-Palmolive (India) Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 1,705.79 Cr (+12.20% YoY) and PAT growth of +4.30% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 22, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 1,705.79 Cr (+12.20% YoY) |
| PAT (Q2) | Rs. 341.57 Cr (+4.30% YoY) |
| EBITDA margin | 27.75% (-282 bps YoY) |
| EPS (Q2) | Rs. 12.56 (+4.30% YoY) |
| Market cap | Rs. 45,829.58 Cr |
| CMP | Rs. 1,685.00 |
Quarter Snapshot
Colgate-Palmolive India delivered 12.2% YoY sales growth to Rs.1,692 Cr with high-single-digit toothpaste volume expansion, marking a second consecutive quarter of double-digit growth. Gross margin expanded 40 bps to 69.6%, but EBITDA margin compressed 282 bps to 27.75% as advertising (15.85% of sales) and other expenses (+27.6%) were deliberately stepped up under the growth-ahead-of-profitability strategy. Management delivered on its stated guidance with a debt-free, cash-rich balance sheet (Rs.1,588 Cr cash, ROCE 121%) supporting the ~100% dividend payout policy.
Key Investment Insights
Key Positives
- Sales grew 12.2% YoY to Rs.1,692 Cr, second consecutive quarter of double-digit growth
- High-single-digit toothpaste volume expansion driven by Premium range and Colgate MaxFresh
- Gross margin expanded 40 bps YoY to 69.6% under the Funding the Growth program
- PAT grew 4.3% YoY (5.5% ex-one-offs per management); H1 normalized PAT grew 6.0% YoY
- Debt-free balance sheet with Rs.1,588 Cr cash (43.6% of assets); ROCE at 121%
- First interim dividend of Rs.24/share (Rs.653 Cr) declared, consistent with ~100% payout policy
- Capex up 61% YoY with CWIP up 91% to Rs.5,200 Lakh, indicating capacity expansion in progress
Risk Factors
- EBITDA margin compressed 282 bps YoY to 27.75% as total expenses grew 16.0% vs 12.2% revenue growth
- Other expenses rose 27.6% YoY and advertising 19.1% YoY, both outpacing revenue
- Employee costs grew 15.1% YoY, ahead of revenue growth
- H1 CFO declined 15.9% YoY to Rs.83,879 Lakh on working capital drag (inventory build of Rs.4,412 Lakh)
- EBITDA grew only 1.9% YoY vs 12.2% revenue growth
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.